カテゴリー： 世界, 医療/バイオ, Grand View Research

世界のアスペルギルス症治療市場2023-2030：タイプ別（アレルギー性、慢性、侵襲性）、薬剤クラス別（抗真菌薬）、投与経路別、流通チャネル別、地域別

【英語タイトル】Aspergillosis Treatment Market Size, Share & Trends Analysis Report By Type (Allergic, Chronic, Invasive), By Drug Class (Antifungal), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23NOV045）・商品コード：GRV23NOV045
・発行会社（調査会社）：Grand View Research
・発行日：2023年9月
・ページ数：100
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥880,600見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,028,600見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,324,600見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

アスペルギルス症治療市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界のアスペルギルス症治療市場規模は、2023年から2030年にかけて年平均成長率3.99%を記録し、2030年までに57.9億米ドルに達する見込みです。アスペルギルス症は、特に免疫不全者の間で罹患率が上昇しており、革新的な治療アプローチの需要に拍車をかけています。医療技術と薬剤開発の急速な進歩により、より的を絞った効果的な治療法が導入され、患者の転帰と治療効果が向上しています。認知度と診断能力の向上は、早期発見と迅速な治療開始に貢献し、様々な薬剤に対する需要をさらに高めています。既存の治療パラダイムでは、抗生物質や副腎皮質ステロイドに加え、アゾール系抗真菌薬（イトラコナゾールやボリコナゾールなど）の使用が主流です。

F2G、TFF Pharmaceuticals、Scynexis、Pulmocideなどの著名な企業が、侵襲性アスペルギルス症治療の展望を再構築する可能性を秘めた革新的な治療戦略を発表しています。このような候補薬の上市に成功すれば、この市場における既成の製薬企業のリーダーにとって大きな挑戦となる可能性があります。この挑戦は、確立された標準治療に革命をもたらし、それによって患者に革新的なアプローチを提供する能力から生じるでしょう。

現在、企業や研究者は、研究開発（R&D）や治療の展望に影響を与える可能性のある課題を評価し、潜在的な機会を特定することに取り組んでいます。この分野で現在進行中の取り組みは、アスペルギルス症への対処と管理の強化を目指した革新的な戦略が中心となっています。例えば、パルマトリックス社は2022年4月、PUR1800を含む同社のナロースペクトラムキナーゼ阻害剤（NSKI）ポートフォリオの完全な権利回復を発表しました。

この決定は、Johnson & Johnson's Enterprise Innovationが、Pulmatrixと以前に締結したライセンス契約、開発契約、商業化契約を終了することを決定した後に下されたものです。これを受け、PulmatrixはPUR1800の開発を進める意向を表明しました。同社は、継続的な臨床評価と毒性試験を実施することにより、本化合物の開発を進めていく予定です。これらの試みは、慢性閉塞性肺疾患（COPD）の急性増悪やその他の慢性呼吸器疾患に焦点を当てたプログラムを強化するために行われます。

アスペルギルス症治療市場レポートハイライト

- タイプ別では、アレルギー性セグメントが2022年に最大の売上シェアを占めました。この成長は、特に喘息や嚢胞性線維症患者が罹患するアレルギー性気管支肺アスペルギルス症（ABPA）のような疾患において、有病率が高く、疾患の症状が軽いことに起因しています。

- 薬剤クラス別では、抗真菌薬セグメントが2022年に最大の売上シェアを占めました。この成長は、アスペルギルス症感染に対する有効性と、主要な治療オプションとしての幅広い使用によるものです。

- 投与経路別では、経口薬が2022年に最大の売上シェアを占めました。この成長は、その利便性と患者に優しい投与方法によるもので、医療提供者と患者の両方にとって好ましい選択肢となっています。

- 流通チャネル別では、病院薬局セグメントが2022年に47.59%のシェアで市場を支配でした。この成長は、アスペルギルス症の治療薬を効果的に提供し、利用しやすくする上で、病院を拠点とする流通チャネルが極めて重要な役割を果たしているためです。

- 2022年の市場は北米が支配的でした。この優位性は、同地域の高度な医療インフラ、ダイナミックな研究開発（R&D）努力、最先端医療技術へのアクセスを強調する要因の合流によるものと考えられます。

第1章 調査方法・範囲
第2章 エグゼクティブサマリー
第3章 市場変数・傾向・範囲
第4章 世界のアスペルギルス症治療市場：タイプ別セグメント分析
第5章 世界のアスペルギルス症治療市場：薬剤クラス別セグメント分析
第6章 世界のアスペルギルス症治療市場：投与経路別セグメント分析
第7章 世界のアスペルギルス症治療市場：流通チャネル別セグメント分析
第8章 世界のアスペルギルス症治療市場：地域別セグメント分析
第9章 競争状況

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Type Segment
1.1.1.2. Drug Class
1.1.1.3. Route of Administration
1.1.1.4. Distribution Channel
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objective
1.4.1. Objective 1
1.4.2. Objective2
1.4.3. Objective 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis:
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.4.1. Increasing Prevalence of Aspergillosis
3.4.2. Advancements in Medical Research
3.4.3. Awareness and Diagnosis Improvement
3.5. Market Restraint Analysis
3.5.1. Limited Treatment Options
3.5.2. High Treatment Costs
3.6. Industry Analysis Tools
3.6.1. Porter’s Five Forces Analysis
3.6.2. PESTEL Analysis
3.6.3. COVID-19 Impact Analysis
Chapter 4. Aspergillosis Treatment Market: By Type Segment Analysis
4.1. Aspergillosis Treatment: Market Share Analysis, 2022 & 2030
4.2. Allergic Aspergillosis
4.2.1. Allergic Aspergillosis Market, 2018 – 2030 (USD Million)
4.3. Chronic Aspergillosis
4.3.1. Chronic Aspergillosis Market, 2018 – 2030 (USD Million)
4.4. Invasive Aspergillosis
4.4.1. Invasive Aspergillosis Market, 2018 – 2030 (USD Million)
Chapter 5. Aspergillosis Treatment Market: Drug Class Segment Analysis
5.1. Aspergillosis Treatment: Market Share Analysis, 2022 & 2030
5.2. Antifungal Drugs
5.2.1. Antifungal Drugs Market, 2018 – 2030 (USD Million)
5.2.1.1. Azoles
5.2.1.2. Echinocandins
5.2.1.3. Polyenes
5.2.1.4. Allylamines
5.2.1.5. Others
5.3. Others
5.3.1. Others Market, 2018 – 2030 (USD Million)
Chapter 6. Aspergillosis Treatment Market: Route of Administration Segment Analysis
6.1. Aspergillosis Treatment: Market Share Analysis, 2022 & 2030
6.2. Oral Drugs
6.2.1. Oral Drugs Market, 2018 – 2030 (USD Million)
6.3. Ointments
6.3.1. Ointments Market, 2018 – 2030 (USD Million)
6.4. Powders
6.4.1. Powders Market, 2018 – 2030 (USD Million)
6.5. Others
6.5.1. Others Market, 2018 – 2030 (USD Million)
Chapter 7. Aspergillosis Treatment Market: By Distribution Channel Segment Analysis
7.1. Aspergillosis Treatment: Market Share Analysis, 2022 & 2030
7.2. Hospital Pharmacy
7.2.1. Hospital Pharmacy Market, 2018 – 2030 (USD Million)
7.3. Retail Pharmacy
7.3.1. Retail Pharmacy Market, 2018 – 2030 (USD Million)
7.4. Others
7.4.1. Others Market, 2018 – 2030 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Aspergillosis Treatment Market Share By Region, 2022 & 2030
8.2. North America
8.2.1. North Aspergillosis Treatment Market, 2018 – 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. Key Country Dynamics
8.2.2.2. Competitive Scenario
8.2.2.3. Regulatory Framework
8.2.2.4. U.S. Aspergillosis Treatment Market, 2018 – 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Key Country Dynamics
8.2.3.2. Competitive Scenario
8.2.3.3. Regulatory Framework
8.2.3.4. Canada Aspergillosis Treatment Market, 2018 – 2030 (USD Million)
8.3. Europe
8.3.1. Europe Aspergillosis Treatment Market, 2018 – 2030 (USD Million)
8.3.2. UK
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory Framework
8.3.2.4. UK Aspergillosis Treatment Market, 2018 – 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. Germany Aspergillosis Treatment Market, 2018 – 2030 (USD Million)
8.3.4. France
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Framework
8.3.4.4. France Aspergillosis Treatment Market, 2018 – 2030 (USD Million)
8.3.5. Italy
8.3.5.1. Key Country Dynamics
8.3.5.2. Competitive Scenario
8.3.5.3. Regulatory Framework
8.3.5.4. Italy Aspergillosis Treatment Market, 2018 – 2030 (USD Million)
8.3.6. Spain
8.3.6.1. Key Country Dynamics
8.3.6.2. Competitive Scenario
8.3.6.3. Regulatory Framework
8.3.6.4. Spain Aspergillosis Treatment Market, 2018 – 2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Key Country Dynamics
8.3.7.2. Competitive Scenario
8.3.7.3. Regulatory Framework
8.3.7.4. Denmark Aspergillosis Treatment Market, 2018 – 2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Key Country Dynamics
8.3.8.2. Competitive Scenario
8.3.8.3. Regulatory Framework
8.3.8.4. Sweden Aspergillosis Treatment Market, 2018 – 2030 (USD Million)
8.3.9. Norway
8.3.9.1. Key Country Dynamics
8.3.9.2. Competitive Scenario
8.3.9.3. Regulatory Framework
8.3.9.4. Norway Aspergillosis Treatment Market, 2018 – 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Aspergillosis Treatment Market, 2018 – 2030 (USD Million)
8.4.2. Japan
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. Japan Aspergillosis Treatment Market, 2018 – 2030 (USD Million)
8.4.3. China
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. China Aspergillosis Treatment Market, 2018 – 2030 (USD Million)
8.4.4. India
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. India Aspergillosis Treatment Market, 2018 – 2030 (USD Million)
8.4.5. Australia
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Framework
8.4.5.4. Australia Aspergillosis Treatment Market, 2018 – 2030 (USD Million)
8.4.6. Thailand
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Framework
8.4.6.4. Thailand Aspergillosis Treatment Market, 2018 – 2030 (USD Million)
8.4.7. South Korea
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory Framework
8.4.7.4. South Korea Aspergillosis Treatment Market, 2018 – 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America Aspergillosis Treatment Market, 2018 – 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Key Country Dynamics
8.5.2.2. Target Disease Prevalence
8.5.2.3. Competitive Scenario
8.5.2.4. Regulatory Framework
8.5.2.5. Brazil Aspergillosis Treatment Market, 2018 – 2030 (USD Million)
8.5.3. Mexico
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. Mexico Aspergillosis Treatment Market, 2018 – 2030 (USD Million)
8.5.4. Argentina
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Framework
8.5.4.4. Argentina Aspergillosis Treatment Market, 2018 – 2030 (USD Million)
8.6. MEA
8.6.1. SWOT Analysis
8.6.2. MEA Aspergillosis Treatment Market, 2018 – 2030 (USD Million)
8.6.3. South Africa
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. South Africa Aspergillosis Treatment Market, 2018 – 2030 (USD Million)
8.6.4. Saudi Arabia
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. Saudi Arabia Aspergillosis Treatment Market, 2018 – 2030 (USD Million)
8.6.5. UAE
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. UAE Aspergillosis Treatment Market, 2018 – 2030 (USD Million)
8.6.6. Kuwait
8.6.6.1. Key Country Dynamics
8.6.6.2. Competitive Scenario
8.6.6.3. Regulatory Framework
8.6.6.4. Kuwait Aspergillosis Treatment Market, 2018 – 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Market Share Analysis, 2022
9.4. Company Profiles/Listing
9.4.1. Pfizer, Inc
9.4.1.1. Overview
9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Merck & Co
9.4.2.1. Overview
9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. F2G
9.4.3.1. Overview
9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. Novartis AG;
9.4.4.1. Overview
9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Astellas Pharma Inc
9.4.5.1. Overview
9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. Bayer AG
9.4.6.1. Overview
9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Mayne Pharma Group Limited
9.4.7.1. Overview
9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. PULMATRiX
9.4.8.1. Overview
9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives

List of Tables

Table 1 List of abbreviations
Table 2 Global aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 3 Global aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 4 Global aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 5 Global aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 6 Global aspergillosis treatment market, by region, 2018 - 2030 (USD Million)
Table 7 North America aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 8 North America aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 9 North America aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 10 North America aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 11 North America aspergillosis treatment market, by country, 2018 - 2030 (USD Million)
Table 12 U.S. aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 13 U.S. aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 14 U.S. aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 15 U.S. aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 16 Canada aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 17 Canada aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 18 Canada aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 19 Canada aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 20 Europe aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 21 Europe aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 22 Europe aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 23 Europe aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 24 Europe aspergillosis treatment market, by country, 2018 - 2030 (USD Million)
Table 25 UK aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 26 UK aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 27 UK aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 28 UK aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 29 Germany aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 30 Germany aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 31 Germany aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 32 Germany aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 33 France aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 34 France aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 35 France aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 36 France aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 37 Italy aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 38 Italy aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 39 Italy aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 40 Italy aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 41 Spain aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 42 Spain aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 43 Spain aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 44 Spain aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 45 Denmark aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 46 Denmark aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 47 Denmark aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 48 Denmark aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 49 Sweden aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 50 Sweden aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 51 Sweden aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 52 Sweden aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 53 Norway aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 54 Norway aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 55 Norway aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 56 Norway aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 57 Asia Pacific aspergillosis treatment market, by country, 2018 - 2030 (USD Million)
Table 58 Asia Pacific aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 59 Asia Pacific aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 60 Asia Pacific aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 61 Asia Pacific aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 62 Asia Pacific aspergillosis treatment market, by country, 2018 - 2030 (USD Million)
Table 63 Japan aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 64 Japan aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 65 Japan aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 66 Japan aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 67 China aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 68 China aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 69 China aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 70 China aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 71 India aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 72 India aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 73 India aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 74 India aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 75 Australia aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 76 Australia aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 77 Australia aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 78 Australia aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 79 Thailand aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 80 Thailand aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 81 Thailand aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 82 Thailand aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 83 South Korea aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 84 South Korea aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 85 South Korea aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 86 South Korea aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 87 Latin America aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 88 Latin America aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 89 Latin America aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 90 Latin America aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 91 Latin America aspergillosis treatment market, by country, 2018 - 2030 (USD Million
Table 92 Brazil aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 93 Brazil aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 94 Brazil aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 95 Brazil aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 96 Mexico aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 97 Mexico aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 98 Mexico aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 99 Mexico aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 100 Argentina aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 101 Argentina aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 102 Argentina aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 103 Argentina aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 104 Middle East & Africa aspergillosis treatment market, by country, 2018 - 2030 (USD Million)
Table 105 Middle East & Africa aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 106 Middle East & Africa aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 107 Middle East & Africa aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 108 Middle East & Africa aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 109 Middle East & Africa aspergillosis treatment market, by country, 2018 - 2030 (USD Million)
Table 110 South Africa aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 111 South Africa aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 112 South Africa aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 113 South Africa aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 116 Saudi Arabia aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 117 Saudi Arabia aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 118 UAE aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 119 UAE aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 120 UAE aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 121 UAE aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 122 Kuwait aspergillosis treatment market, by type, 2018 - 2030 (USD Million)
Table 123 Kuwait aspergillosis treatment market, by drug class, 2018 - 2030 (USD Million)
Table 124 Kuwait aspergillosis treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 125 Kuwait aspergillosis treatment market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Aspergillosis treatment market segmentation
Fig. 8 Market snapshot, 2022
Fig. 9 Market Trends & outlook
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 13 Porter’s Five Forces analysis
Fig. 14 Market penetration & growth prospect mapping, 2022
Fig. 15 Global aspergillosis treatment market: By Type movement analysis
Fig. 16 Global aspergillosis treatment market, for allergic aspergillosis, 2018 - 2030 (USD Million)
Fig. 17 Global aspergillosis treatment market, for chronic aspergillosis, 2018 - 2030 (USD Million)
Fig. 18 Global aspergillosis treatment market, for invasive aspergillosis, 2018 - 2030 (USD Million)
Fig. 19 Global aspergillosis treatment market: Drug Class movement analysis
Fig. 20 Global aspergillosis treatment market, for antifungal drugs (Azoles, Echinocandins, Polyenes, Allylamines, Others) 2018 - 2030 (USD Million)
Fig. 21 Global aspergillosis treatment market, for others, 2018 - 2030 (USD Million)
Fig. 22 Global aspergillosis treatment market: Route of Administration movement analysis
Fig. 23 Global aspergillosis treatment market, for oral drugs, 2018 - 2030 (USD Million)
Fig. 24 Global aspergillosis treatment market, for ointments, 2018 - 2030 (USD Million)
Fig. 25 Global aspergillosis treatment market, for powders, 2018 - 2030 (USD Million)
Fig. 26 Global aspergillosis treatment market, for others, 2018 - 2030 (USD Million)
Fig. 27 Global aspergillosis treatment market: Distribution Chanel movement analysis
Fig. 28 Global aspergillosis treatment market, for hospital pharmacies, 2018 - 2030 (USD Million)
Fig. 29 Global aspergillosis treatment market, for retail pharmacy, 2018 - 2030 (USD Million)
Fig. 30 Global aspergillosis treatment market, for other pharmacies, 2018 - 2030 (USD Million)
Fig. 31 Regional marketplace: Key takeaways
Fig. 32 Regional outlook, 2022 & 2030
Fig. 33 Global aspergillosis treatment market: Region movement analysis
Fig. 34 North America aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 35 U.S. aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 36 Canada aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 37 Europe aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 38 Germany aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 39 UK aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 40 France aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 41 Italy aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 42 Spain aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 43 Denmark aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 44 Sweden aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 45 Norway aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 46 Asia Pacific aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 47 Japan aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 48 China aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 49 India aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 50 Australia aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 51 South Korea aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 52 Thailand aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 53 Latin America aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 54 Brazil aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 55 Mexico aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 56 Argentina aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 57 Middle East and Africa aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 58 South Africa aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 59 Saudi Arabia aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 60 UAE aspergillosis treatment market, 2018 - 2030 (USD Million)
Fig. 61 Kuwait aspergillosis treatment market, 2018 - 2030 (USD Million)

★調査レポート[世界のアスペルギルス症治療市場2023-2030：タイプ別（アレルギー性、慢性、侵襲性）、薬剤クラス別（抗真菌薬）、投与経路別、流通チャネル別、地域別] (コード：GRV23NOV045)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のアスペルギルス症治療市場2023-2030：タイプ別（アレルギー性、慢性、侵襲性）、薬剤クラス別（抗真菌薬）、投与経路別、流通チャネル別、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の抗感染症薬市場2023-2030：種類/薬剤クラス別（抗ウイルス薬、抗真菌薬）、投与経路別、流通チャネル別、地域別
  • 世界の抗ウイルス薬市場2023-2030：タイプ別（ブランド、ジェネリック）、薬剤クラス別、流通チャネル別（病院薬局、小売薬局）、用途別、地域別
  • 世界のピーナッツアレルギー治療薬市場2024-2030：薬剤クラス別（抗ヒスタミン薬、エピネフリン）、投与経路別、流通チャネル別、地域別
  • 世界の炎症性腸疾患（IBD）治療市場2023-2030：種類別（クローン病、潰瘍性大腸炎）、薬剤クラス別、投与経路別、流通チャネル別、地域別
  • 世界の降圧薬市場2024-2030：薬剤クラス別（利尿薬、ACE阻害薬）、種類別（一次、二次）、投与経路別、流通チャネル別、地域別
  • 世界の抗感染症薬市場2023-2031：薬剤クラス別（抗菌薬、抗ウイルス薬、抗真菌薬、その他）、投与経路別（経口、非経口、その他）
  • 世界の急性呼吸窮迫症候群（ARDS）治療薬市場2023-2030：薬剤クラス別（血管収縮薬、気管支拡張薬、ステロイド、抗生物質、その他）、投与経路別（経口、注射、吸入）、流通チャネル別（病院薬局、小売薬局、オンライン薬局、その他）、地域別
  • 世界のヘパリン市場2024-2030：タイプ別、投与経路別、用途別、エンドユーザー別（外来患者、入院患者）、供給源別、地域別
  • 世界の緑内障市場2023-2030：疾患種類別（開放隅角緑内障、閉塞隅角緑内障）、薬剤クラス別（プロスタグランジン類縁体、ベータ遮断薬）、流通チャネル別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆